Q4 2024 Summary
Published Mar 6, 2025, 10:31 PM UTCMetric | YoY Change | Reason |
---|---|---|
Total Revenue | +18% (from $60,561k to $71,748k) | The 18% increase is driven by robust market expansion and consistent revenue growth initiatives that built on prior period progress. This growth reflects continued product and market investments that expanded the customer base, similar to the enhancements seen in previous quarters. |
Operating Income | +465% (from ~$11,230k to ~$63,431k) | The significant 465% YoY improvement resulted from operational efficiencies, cost controls, and higher revenue execution. Building on earlier improvements, the company enhanced its margin profile through better cost management and scale, which dramatically boosted operating profitability despite the lower baseline in the prior period. |
Net Income | Over +400% (from ~$19,559k to ~$98,158k) | A more than 400% jump in net income is attributable to the combination of improved sales performance and significant cost optimizations that enhanced profitability. This leap builds on past revenue momentum and tighter cost discipline, enabling the company to convert higher revenue into substantially better bottom-line results. |
Basic EPS (and Diluted EPS) | +413% (from $0.23 to $1.18) | The 413% increase in EPS reflects the dramatic improvement in net income and efficient capital utilization, as earnings expanded considerably against a lower per-share impact in Q4 2023. This performance is the result of both increased operational profit and favorable share count dynamics already evolving from earlier periods. |
Depreciation & Amortization | +85% (from ~$4,940k to ~$9,122k) | The 85% rise is primarily due to significant capital investments in property, plant, and equipment along with asset reclassifications that increased amortization expense. This trend follows previous investment patterns and reflects an ongoing strategy to scale operations and improve production capabilities. |
Research and Development | -17% (from ~$8,102k to ~$6,738k) | The 17% reduction in R&D expenses indicates a strategic shift toward cost savings, likely through reducing outsourced consulting and focusing on internal efficiencies. Such reductions build on earlier cost optimization efforts, allowing the company to streamline its innovation spend without compromising long-term product development initiatives. |
Metric | Period | Guidance | Actual | Performance |
---|---|---|---|---|
Net Revenue | FY 2024 | $252 million to $256 million | $256.2 million (sum of Q1-Q4 2024 revenue: 61,082 + 61,016 + 62,336 + 71,748 โ 256,182 thousands) | Beat |
Gross Margin | FY 2024 | ~75% | 74.7% (calculated from total FY 2024 Revenue minus COGS: (256,182 โ 64,693) รท 256,182) | Met |